Skip to content

The impact of fecal microbiota transplantation on patients' gastric function

The impact of fecal microbiota transplantation on patients' gastric function

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093149
Enrollment
Unknown
Registered
2024-11-29
Start date
2024-11-30
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome, Helicobacter pylori infection, Ulcerative colitis, Gastric ulcer, Functional dyspepsia.

Interventions

Abnormal gastric function group:None

Sponsors

The First Affiliated Hospital of Guangdong Pharmaceutical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Ages 18-80, including patients aged 18 and 80. 2. Patients who have undergone 2 or more WMT treatments at our department due to diseases such as Irritable Bowel Syndrome, Ulcerative Colitis, Gout, or Specific Dermatitis.

Exclusion criteria

Exclusion criteria: Mentally abnormal, unable to take care of oneself.

Design outcomes

Primary

MeasureTime frame
Serum Gastric Function Tests;13C Urea Breath Test;Helicobacter pylori antibodies;

Secondary

MeasureTime frame
Helicobacter pylori strain typing;Infect four items;

Countries

China

Contacts

Public ContactHe Xingxiang

The First Affiliated Hospital of Guangdong Pharmaceutical University

13724887928@qq.com+86 137 2488 7928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026